Stenotrophomonas maltophilia bacteraemia in Turkish children

Annals of Tropical Paediatrics

Volumn 28, Issue 2, 2008, Pages 129-136

  Güriz, Haluk ^a   Çiftçi, Ergin ^a   Ayberkin, Eda ^a   Aysev, Derya ^a   Ince, Erdal ^a   Arsan, Saadet ^a   Yavuz, Gülsan ^a   Doǧru, Ülker ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFALOTIN; CEFEPIME; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN; QUINOLONE DERIVATIVE; SULPERAZON; SULTAMICILLIN; TETRACYCLINE; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; BROTH DILUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISK DIFFUSION; FEBRILE NEUTROPENIA; FEMALE; HOSPITAL INFECTION; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTOSIS; MALE; MORTALITY; PRESCHOOL CHILD; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SEPTICEMIA; STENOTROPHOMONAS MALTOPHILIA; TURKEY (REPUBLIC);

ADOLESCENT; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; PROGNOSIS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; STENOTROPHOMONAS MALTOPHILIA; TREATMENT OUTCOME;

EID: 48749099928     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/146532808X302152     Document Type: Article

References (19)

1. Senol E. Stenotrophomonas maltophilia: The significance and role as a nosocomial pathogen. J Hosp Infect 2004; 57:1-7.
2. Micozzi A, Venditti M, Monaco M, et al. Bacteraemia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000; 31:705-11.
3. Labarca JA, Leber AL, Kern VL, et al. Outbreak of Stenotrophomonas maltophilia bacteraemia in allogeneic bone marrow transplant patients: Role of severe neutropenia and mucositis. Clin Infect Dis 2000; 30:195-7.
4. Ansari SR, Hanna H, Hachem R, Jiang Y, Rolston K. Raad I. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer 2007; 109:2615-22.
5. Krcmery V, Trupl J, Svetlansky I. Susceptibility to antimicrobial agents of Stenotrophomonas maltophilia isolated from patients with cancer and bacteraemia. Clin Infect Dis 2001; 32:1656.
6. Sattler CA, Mason EO Jr, Kaplan SL. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital. Clin Infect Dis 2000; 31:1321-30.
7. Wu PS, Lu CY, Chang LY, et al. Stenotrophomonas maltophilia bacteraemia in pediatric patients-a 10-year analysis. J Microbiol Immunol Infect 2006; 39:144-9.
8. Kagen J, Zaoutis TE, McGowan KL, Luan X, Shah SS. Bloodstream infection caused by Stenotrophomonas maltophilia in children. Pediatr Infect Dis J 2007; 26:508-12.
9. Krueger TS, Clark EA. Nix DE. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations. Diagn Microbiol Infect Dis 2001; 41:71-8
10. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard, 6th edn. Wayne, PA: National Committee for Clinical Laboratory Standards, NCCLS Document M7-A6, 2003.
11. Performance Standards For Antimicrobial Disk Susceptibility Tests: Approved Standard, 8th edn. Wayne, PA: National Committee for Clinical Laboratory Standards, NCCLS Document M2-A8, 2003.
12. Valdezate S, Vindel A, Martin-Davila P, Del Saz BS, Baquero F, Canton R. High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004; 42:693-9.
13. James LP, Abdel-Rahman S, Farrar HC, Jacobs RF. Antimicrobial agents. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2nd edn. New York: Churchill Livingstone, 2003; 1458-510.
14. Tatman-Otkun M, Gürcan S, Ozer B, Aydoslu B, Bukavaz S. 'Me antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness. BMC Microbiol 2005; 5:24.
15. Al-Jasser AM. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: An increasing problem. Ann Clin Microbiol Antimicrob 2006; 5:23.
16. Liaw SJ, Teng LJ, Hsueh PR, Ho SW, Luh KT. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia. J Formos Med Assoc 2002; 101:495-501.
17. Zelenitsky SA, Iacovides H, Ariano RE, Harding GK. Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis 2005; 51:39-43.
18. Boktour M, Hanna H, Ansari S, et al. Central venous catheter and Stenotrophomonas maltophilia bacteraemia in cancer patients. Cancer 2006; 106:1967-73.
19. Lai CH, Wong WW, Chin C, et al. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients. Clin Microbiol Infect 2006; 12:986-91.